logo

For the Inventor, By the Inventor

Yehud, Israel

Tamar Nidam

This inventor holds 31 USPTO granted patents and 2 published patent applications, primarily in Pharmaceutical Chemistry. Top assignees: Teva Pharmaceutical Industries Limited, Assia Chemical Industries Ltd.. Active years: 2002-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tamar Nidam. Retrieved from https://idiyas.com/inventor/tamar-nidam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 

% Patents Active = 48.4

Average Co-Inventor Count = 4.7

ph-index = 5

Forward Citations = 99(Granted Patents)


Location History:

  • Yahud, IL (2002 - 2005)
  • Yehud, IL (2002 - 2022)

Company Filing History:

goldMedal28 out of 505 
 
Teva Pharmaceutical Industries Limited
 patents
silverMedal3 out of 43 
 
Assia Chemical Industries Ltd.
 patents

Years Active: 2002-2022

Loading Chart...
Areas of Expertise:
Solid State Forms
Pharmaceutical Chemistry
Purification Methods
Crystal Polymorphs
Valbenazine
Netarsudil Mesylate
Sertraline Hydrochloride
Zonisamide
Gabapentin Enacarbil
Lansoprazole
Linezolid Intermediate
6-Hydroxy-3,4-Dihydroquinolinone
31 patents (USPTO):Explore Patents
1. 11242341 - Solid state forms of valbenazine (2022-02-08),
2. 10584100 - Solid state forms of netarsudil mesylate (2020-03-10),
3. 10442770 - Solid state forms of netarsudil mesylate (2019-10-15),
4. 8283487 - Processes for the preparation and purification of gabapentin enacarbil (2012-10-09),
5. 8063250 - Crystal forms of O-desmethylvenlafaxine fumarate (2011-11-22),
6. 7884226 - Purification of rosuvatatin intermediate by thin film evaporation and chemical method (2011-02-08),
7. 7667037 - Processes for preparation of ziprasidone (2010-02-23),
8. 7622588 - Method for the purification of lansoprazole (2009-11-24),
9. 7319171 - Sertraline hydrochloride form II and methods for the preparation thereof (2008-01-15),
10. 7291614 - Processes for the preparation of linezolid intermediate (2007-11-06),
11. 7196222 - Sertraline hydrochloride form II and methods for the preparation thereof (2007-03-27),
12. 7060837 - Method for the purification of lansoprazole (2006-06-13),
13. 7022881 - Sertraline hydrochloride polymorphs (2006-04-04),
14. 7022859 - Method for the purification of lansoprazole (2006-04-04),
15. 7015330 - Sulfonation method for zonisamide intermediate in zonisamide synthesis and their novel crystal forms (2006-03-21),

Title: The Innovative Journey of Tamar Nidam

Introduction: Tamar Nidam, a visionary inventor hailing from Yehud, Israel, has made significant contributions to the world of innovations with his groundbreaking ideas and inventions.

Latest Patents: Tamar Nidam holds several patents in various fields, including technology, healthcare, and sustainability. His most recent patent focuses on a revolutionary method for renewable energy production, showcasing his commitment to environmental advancements.

Career Highlights: Throughout his illustrious career, Tamar Nidam has been recognized for his inventive spirit and problem-solving abilities. His inventions have not only improved existing technologies but have also paved the way for new industry standards.

Collaborations: Tamar Nidam has collaborated with leading research institutions and universities to further his innovative projects. His partnerships with experts in diverse fields have resulted in cutting-edge solutions that have the potential to shape the future.

Conclusion: Tamar Nidam's passion for innovation, coupled with his relentless drive to push boundaries, has established him as a prominent figure in the world of inventors. His dedication to creating impactful solutions underscores his commitment to making the world a better place through his inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…